MDT perspectives on indications for immune checkpoint inhibitors in patients with solid tumours

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the current and upcoming indications for immune checkpoint inhibitors in patients with solid tumours and review general considerations for their use.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/